231 related articles for article (PubMed ID: 16738535)
1. Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise.
Brines M; Cerami A
Kidney Int; 2006 Jul; 70(2):246-50. PubMed ID: 16738535
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic potential of erythropoiesis-stimulating agents for tissue protection: a tale of two receptors.
Brines M
Blood Purif; 2010; 29(2):86-92. PubMed ID: 20093809
[TBL] [Abstract][Full Text] [Related]
3. Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin.
Brines M; Patel NS; Villa P; Brines C; Mennini T; De Paola M; Erbayraktar Z; Erbayraktar S; Sepodes B; Thiemermann C; Ghezzi P; Yamin M; Hand CC; Xie QW; Coleman T; Cerami A
Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10925-30. PubMed ID: 18676614
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor.
Brines M; Grasso G; Fiordaliso F; Sfacteria A; Ghezzi P; Fratelli M; Latini R; Xie QW; Smart J; Su-Rick CJ; Pobre E; Diaz D; Gomez D; Hand C; Coleman T; Cerami A
Proc Natl Acad Sci U S A; 2004 Oct; 101(41):14907-12. PubMed ID: 15456912
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response.
Brines M; Cerami A
J Intern Med; 2008 Nov; 264(5):405-32. PubMed ID: 19017170
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model.
Spandou E; Tsouchnikas I; Karkavelas G; Dounousi E; Simeonidou C; Guiba-Tziampiri O; Tsakiris D
Nephrol Dial Transplant; 2006 Feb; 21(2):330-6. PubMed ID: 16221709
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration.
Broxmeyer HE
J Exp Med; 2013 Feb; 210(2):205-8. PubMed ID: 23401569
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin ameliorates renal ischemia and reperfusion injury via inhibiting tubulointerstitial inflammation.
Hu L; Yang C; Zhao T; Xu M; Tang Q; Yang B; Rong R; Zhu T
J Surg Res; 2012 Jul; 176(1):260-6. PubMed ID: 21816412
[TBL] [Abstract][Full Text] [Related]
10. Unexpected renal actions of erythropoietin.
Westenfelder C
Exp Nephrol; 2002; 10(5-6):294-8. PubMed ID: 12381912
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin in experimental acute renal failure.
Sharples EJ; Yaqoob MM
Nephron Exp Nephrol; 2006; 104(3):e83-8. PubMed ID: 16837817
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin is a multifunctional tissue-protective cytokine.
Erbayraktar S; Yilmaz O; Gökmen N; Brines M
Curr Hematol Rep; 2003 Nov; 2(6):465-70. PubMed ID: 14561390
[TBL] [Abstract][Full Text] [Related]
13. The Protective and Reparative Role of Colony-Stimulating Factors in the Brain with Cerebral Ischemia/Reperfusion Injury.
Patel AMR; Apaijai N; Chattipakorn N; Chattipakorn SC
Neuroendocrinology; 2021; 111(11):1029-1065. PubMed ID: 33075777
[TBL] [Abstract][Full Text] [Related]
14. Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agents.
Tanaka T; Nangaku M
Exp Cell Res; 2012 May; 318(9):1068-73. PubMed ID: 22414872
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of erythropoietin on renal ischemia and reperfusion injury.
Ates E; Yalcin AU; Yilmaz S; Koken T; Tokyol C
ANZ J Surg; 2005 Dec; 75(12):1100-5. PubMed ID: 16398819
[TBL] [Abstract][Full Text] [Related]
16. Is the β Common Receptor the Key Molecule for the Protective Effect of Erythropoietin?
Yang Z; Wang R; Zheng Y; Luo Y
Aging Dis; 2023 Apr; 14(2):287-289. PubMed ID: 37008064
[TBL] [Abstract][Full Text] [Related]
17. [Pleiotropic effects of erythropoietin].
Kes P; Basić-Jukić N; Furić-Cunko V
Acta Med Croatica; 2009 Sep; 63 Suppl 1():46-53. PubMed ID: 20232551
[TBL] [Abstract][Full Text] [Related]
18. Helix B surface peptide administered after insult of ischemia reperfusion improved renal function, structure and apoptosis through beta common receptor/erythropoietin receptor and PI3K/Akt pathway in a murine model.
Yang C; Zhao T; Lin M; Zhao Z; Hu L; Jia Y; Xue Y; Xu M; Tang Q; Yang B; Rong R; Zhu T
Exp Biol Med (Maywood); 2013 Jan; 238(1):111-9. PubMed ID: 23479770
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin biology in cancer.
Hardee ME; Arcasoy MO; Blackwell KL; Kirkpatrick JP; Dewhirst MW
Clin Cancer Res; 2006 Jan; 12(2):332-9. PubMed ID: 16428469
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin: a hormone with multiple functions.
Lombardero M; Kovacs K; Scheithauer BW
Pathobiology; 2011; 78(1):41-53. PubMed ID: 21474975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
